Medicare to cover Novo’s obesity drug for some patients
Health Care Dive
MARCH 22, 2024
Two weeks after the FDA updated Wegovy’s label, Medicare changed its stance to allow people with a history of heart disease to receive treatment, a shift that could further boost access to the fast-selling medicine.
Let's personalize your content